肠易激综合征肠道化学敏感性与小肠TRPV通道表达相关
研究纳入26例IBS患者(12例IBS-C,14例IBS-D)和15名健康志愿者,评估脂质灌注后症状、直肠敏感性和小肠TRPV通道表达。脂质灌注后IBS患者症状应答更强,IBS-C和IBS-D直肠感觉阈值低于健康志愿者;IBS-D十二指肠TRPV1和TRPV3表达增高,IBS-C TRPV3增高,TRPV1表达与腹痛及直肠阈值相关。
要点
- 脂质灌注后IBS患者较健康志愿者更易出现疼痛、恶心、饱胀和便急感。
- IBS-C和IBS-D患者直肠感觉和疼痛阈值低于健康志愿者。
- 十二指肠TRPV1表达与腹痛正相关,与直肠感觉和疼痛阈值负相关。
核心结论
- 脂质灌注在IBS患者中引起比健康志愿者更强的症状应答,该应答与小肠TRPV通道表达相关。
- TRPV介导的小肠化学敏感性可能介导IBS餐后症状。
研究设计与样本
- 招募26例IBS患者(12例IBS-C,14例IBS-D)和15名健康志愿者(HV)。
- 采用糖排泄试验评估体内通透性,直肠恒压器评估直肠敏感性,脂质灌注前后进行。
- 进行延长上消化道内镜联合探头共聚焦激光显微内镜(pCLE)观察脂质诱导变化,并获取十二指肠和空肠黏膜活检行转录组学分析。
主要发现
- 脂质灌注后,报告无疼痛、无恶心、无饱胀和无便急感的HV比例高于IBS患者(P < 0.05 for all)。
- 在校正性别和焦虑的模型中,IBS-C和IBS-D患者首次直肠感觉阈值(P = 0.0007)和疼痛阈值(P = 0.004)低于HV。
- 体内小肠通透性和平均pCLE评分在IBS患者与HV间相似;脂质灌注后pCLE评分高于脂质前,但组间无差异。
- 基线十二指肠TRPV1和TRPV3表达在IBS-D中增高,TRPV3在IBS-C中增高。
- 十二指肠TRPV1表达与腹痛相关(r = 0.51,FDR = 0.01),与首次直肠感觉阈值(r = -0.48,FDR = 0.01)和疼痛阈值(r = -0.41,FDR = 0.02)呈负相关。
临床怎么用
- IBS患者餐后症状可能与小肠TRPV通道介导的化学敏感性有关,提示TRPV通道或为潜在干预靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Irritable bowel syndrome (IBS) patients often experience meal-associated symptoms. However, the underlying mechanisms are unclear. AIM: To determine small intestinal mechanisms of lipid-induced symptoms and rectal hypersensitivity in IBS METHODS: We recruited 26 IBS patients (12 IBS-C, 14 IBS-D) and 15 healthy volunteers (HV). In vivo permeability was assessed using saccharide excretion assay. Rectal sensitivity was assessed using a barostat before and after small bowel lipid infusion; symptoms were assessed throughout. Next, an extended upper endoscopy with probe-based confocal laser endomicroscopy (pCLE) was performed with changes induced by lipids. Duodenal and jejunal mucosal biopsies were obtained for transcriptomics. RESULTS: Following lipid infusion, a higher proportion of HV than IBS patients reported no pain, no nausea, no fullness and no urgency (P < 0.05 for all). In a model adjusted for sex and anxiety, IBS-C and IBS-D patients had lower thresholds for first rectal sensation (P = 0.0007) and pain (P = 0.004) than HV. In vivo small intestinal permeability and mean pCLE scores were similar between IBS patients and HV. Post-lipid, pCLE scores were higher than pre-lipid but were not different between groups. Baseline duodenal transient receptor potential vanilloid (TRPV) 1 and 3 expression was increased in IBS-D, and TRPV3 in IBS-C. Duodenal TRPV1 expression correlated with abdominal pain (r = 0.51, FDR = 0.01), and inversely with first rectal sensation (r = -0.48, FDR = 0.01) and pain (r = -0.41, FDR = 0.02) thresholds. CONCLUSION: Lipid infusion elicits a greater symptom response in IBS patients than HV, which is associated with small intestinal expression of TRPV channels. TRPV-mediated small intestinal chemosensitivity may mediate post-meal symptoms in IBS.
引用
- Grover M, Berumen A, Peters S, et al. Intestinal chemosensitivity in irritable bowel syndrome associates with small intestinal TRPV channel expression. Aliment Pharmacol Ther. 2021. PMID: 34472640. doi:10.1111/apt.16591
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。